Novel Spectacle Lenses for Nearsightedness
(CEDAR Trial)

Recruiting in Palo Alto (17 mi)

+5 other locations

Age: < 18

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: SightGlass Vision, Inc.

Trial Summary

What is the purpose of this trial?This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects will undergo additional visual performance assessments.

Eligibility Criteria

This trial is for people who were already part of the CYPRESS Extension study and can follow through with the study's assessments. They must have consent from a parent or legal guardian if required. Those with current eye infections, inflammation, or irritation that could affect vision cannot participate.

Inclusion Criteria

Existing subject from the CYPRESS Extension study (CPRO-1802-002)

Ability to comply with study assessments

The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed coy of the form

Exclusion Criteria

I do not have any eye infections or conditions affecting my vision.

Participant Groups

The study is testing a new spectacle lens design against standard lenses in a two-arm parallel group setup. Participants will not keep the glasses but will undergo visual performance evaluations to compare effectiveness.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Test ArmExperimental Treatment1 Intervention

Single vision, impact resistant spectacle lenses; Test Arm

Group II: Control ArmPlacebo Group1 Intervention

Single vision, impact resistant spectacle lenses; Control Arm